AU3727799A - Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment - Google Patents

Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment

Info

Publication number
AU3727799A
AU3727799A AU37277/99A AU3727799A AU3727799A AU 3727799 A AU3727799 A AU 3727799A AU 37277/99 A AU37277/99 A AU 37277/99A AU 3727799 A AU3727799 A AU 3727799A AU 3727799 A AU3727799 A AU 3727799A
Authority
AU
Australia
Prior art keywords
predisposition
epilepsy
diagnosis
monitoring
antiepileptic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37277/99A
Other languages
English (en)
Inventor
Svetlana Dolina
Eugene Pressman
Aaron Rabinkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Neuroprotective Systems Ltd
Original Assignee
Advanced Neuroprotective Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Neuroprotective Systems Ltd filed Critical Advanced Neuroprotective Systems Ltd
Publication of AU3727799A publication Critical patent/AU3727799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2857—Seizure disorders; Epilepsy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37277/99A 1998-05-12 1999-05-12 Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment Abandoned AU3727799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL124444 1998-05-12
IL12444498A IL124444A0 (en) 1998-05-12 1998-05-12 Biochemical approach to diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment
PCT/IL1999/000252 WO1999058968A1 (fr) 1998-05-12 1999-05-12 Diagnostic de la predisposition a l'epilepsie et surveillance de traitement anti-epileptique

Publications (1)

Publication Number Publication Date
AU3727799A true AU3727799A (en) 1999-11-29

Family

ID=11071485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37277/99A Abandoned AU3727799A (en) 1998-05-12 1999-05-12 Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment

Country Status (6)

Country Link
EP (1) EP1093580A4 (fr)
JP (1) JP2002538412A (fr)
AU (1) AU3727799A (fr)
CA (1) CA2332021A1 (fr)
IL (1) IL124444A0 (fr)
WO (1) WO1999058968A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002329570A1 (en) * 2001-10-12 2003-01-30 Pfizer Products Inc. Method of monitoring neuroprotective treatment
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
GB201211120D0 (en) * 2012-06-22 2012-08-01 Bessede Alban Antagonist to an enzyme and/or a metabolite of the kynurenine pathway
GB201322538D0 (en) 2013-06-21 2014-02-05 Immusmol Sas Method for detecting small molecules in a sample
CA2918447A1 (fr) * 2013-07-18 2015-01-22 Dianti Ms Limited Procede et trousse de pronostic pour surveillance de sclerose en plaques (sp)
KR102699211B1 (ko) * 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
EP3801596A4 (fr) * 2018-05-29 2023-01-04 Evogen, Inc. Biomarqueurs et procédés d'évaluation et méthodes de traitement de crises épileptiques par rapport aux crises non-épileptiques/crises autres qu'épileptiques/crises non-épileptiques psychogènes

Also Published As

Publication number Publication date
JP2002538412A (ja) 2002-11-12
IL124444A0 (en) 1998-12-06
EP1093580A1 (fr) 2001-04-25
CA2332021A1 (fr) 1999-11-18
EP1093580A4 (fr) 2001-09-12
WO1999058968A1 (fr) 1999-11-18

Similar Documents

Publication Publication Date Title
AU4986899A (en) Non-invasive glucose monitor
IL128106A0 (en) Non invasive continuous blood glucose monitoring
AU3874200A (en) Monitoring of individual internet usage
GB9522872D0 (en) Improvements relating to physiological monitoring
AU3546899A (en) Maximizing effectiveness of substances used to improve health and well being
AU3980399A (en) Monitoring of and remote access to call center activity
AU4078999A (en) Monitoring catheter and method of using same
AU2003303597A8 (en) Continuous glucose monitoring system and methods of use
AU6744798A (en) Health condition monitor and method of use
AU1450900A (en) Methods of treatment of type 2 diabetes
AUPP711998A0 (en) Wrist mountable monitor
GB9702202D0 (en) Diagnosis of arthritic conditions
AU3522999A (en) Purification of human acid alpha-glucosidase
AU3727799A (en) Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment
AU2513997A (en) Diagnosis and monitoring of neurological disease
AU9086898A (en) Remote monitoring of physiological condition
AU2233495A (en) Treatment or diagnosis of abnormal signal transduction disorders
AU2187595A (en) Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction
AU5624796A (en) Diagnostic and treatment methods relating to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
AU2037800A (en) Diagnosis of human glycosylation disorders
GB9922482D0 (en) Method of diagnosis
GB9819370D0 (en) Rate of change monitoring system
AU3531799A (en) Physiological monitoring of a subject
NZ316343A (en) Diagnosis of nonparaffinophilic microorganisms
AUPN384095A0 (en) Diagnostic and treatment methods relating to autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase